Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of BCG Vaccine Vial vs Ampoule in Indonesian Infants
NCT05124340Phase 2Completed
- Sponsor
- Bio Farma
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in Tuberculosis (TB), sponsored by Bio Farma. Started Dec 2021; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05124340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124340.